The gap between what OHB is achieving and what its share price is saying has rarely looked wider. The Bremen-based space group delivered double-digit revenue growth and a sharp jump in profitability in the first half of the year, yet the stock continues to drift, leaving investors to puzzle over whether the market is simply looking the other way or seeing something the fundamentals don’t.
Revenue climbed 11 percent to €628 million in the first six months, while adjusted EBIT surged 46 percent. The shares, however, were changing hands at €185.60 on the day of the report, down 0.4 percent on the previous session — a muted reaction that has become something of a pattern.
A Buy Rating That Arrived Early
The disconnect isn’t lost on the sell side. Oddo BHF lifted its stance on OHB from “Neutral” to “Buy” at the end of August, a call that landed just days before the company announced its blockbuster IRIS² contract with SES S.A. The timing now looks prescient, though the subsequent price action has done little to validate the optimism.
That contract — covering the construction of 18 satellite platforms for Europe’s IRIS² connectivity programme at a value of just under €1 billion — ranks among the largest in OHB’s corporate history and stands as one of the strategic pillars of the European space industry. Reuters has flagged it as the most significant current catalyst for the stock, and management’s earlier guidance for continued growth in the second half of the year now carries considerably more weight.
Yet the market’s response has been oddly restrained. The shares have managed only a modest improvement since the announcement, with one source putting the gain at 1.4 percent and another at 1.9 percent depending on the measurement window. Analysts describe it as a textbook “sell-the-news” reaction, with investors who had positioned ahead of the announcement choosing to bank profits rather than build positions.
The Technical Picture Tells a Different Story
The fundamental narrative is fighting against a chart that looks distinctly unwell. OHB’s stock trades roughly 23 percent below its 50-day moving average, a sign that the momentum which powered the earlier rally has faded badly. The broader picture is even starker: at current levels, the shares sit about 73 percent below the 52-week high of €688.00 reached in May.
Wednesday’s session offered a glimpse of the volatility that now defines trading in the stock — a 4.6 percent jump to close at €186.40 — but the annualised volatility reading of 77 percent underscores just how jittery the market remains. The recent inclusion in the SDax, which saw OHB take the slot vacated by Klöckner, generated a brief flurry of attention but failed to arrest the downward drift.
Part of the explanation lies in the capital increase approved just over a month ago. The share issuance continues to weigh on the stock as a structural overhang, and market observers suggest it accounts for a meaningful portion of the divergence between the operational story and the share price. Rising oil prices have added to the pressure, prompting profit-taking across defence and aerospace names that had run hard in recent months, including Rheinmetall.
Should investors sell immediately? Or is it worth buying OHB SE?
A Greek Beachhead and a Busy Order Book
Away from the daily noise of the ticker, OHB continues to broaden its international footprint. On Thursday, the company signed a cooperation agreement in Heraklion on Crete alongside the Greek research institute ITE and its own subsidiary OHB-Hellas, focused on space technologies.
The agreement is tied to the SPACE-Crete project, which carries €15 million in EU funding — the largest initiative of its kind in Greece and the second-largest in Europe. Separate investment of €25 million from Greece’s recovery and resilience plan will fund new ITE institute facilities, underscoring the strategic importance Athens attaches to the project.
The group’s scale is now considerable: roughly 4,000 employees and an annual budget of €1.3 billion. The SES order for IRIS² remains the central growth driver in the order book, but the Greek cooperation demonstrates that OHB is no longer dependent on any single programme or geography.
What Comes Next
The real test arrives on November 12, when OHB is scheduled to publish third-quarter figures. That report will reveal whether the IRIS² contract has begun to feed through to the guidance and whether the growth promised for the second half is translating into tangible numbers.
Until then, the stock presents an unusual dilemma. The operational case is arguably as strong as it has been in years — double-digit revenue growth, a dramatically improved earnings picture, a billion-euro anchor contract and expanding international partnerships. The technical picture, by contrast, remains damaged, with the capital increase casting a shadow that positive news has so far failed to lift.
For investors willing to look through the near-term noise, the correction may have created a more attractive entry point. But the past few weeks have demonstrated that in OHB’s case, good news and good share price performance are not always the same thing.
Ad
OHB SE Stock: Buy or Sell?! New OHB SE Analysis from September 4 delivers the answer:
The latest OHB SE figures speak for themselves: Urgent action needed for OHB SE investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 4.
OHB SE: Buy or sell? Read more here...
